Conjugated linoleic acid (CLA) A
Meta-analysis: about 0.1 kg of fat per week at 3.2 g/day — in practice almost imperceptible
Citable fact
«Conjugated linoleic acid (CLA)» — evidence level A. Dosage: Usually 3–4 g per day of the isomer mixture. In a meta-analysis at a median dose of 3.2 g/day, fat loss relative to placebo was 0.09 ± 0.08 kg per week, that is about 0.4 kg per month and about 1 kg over 12 weeks. The effect is approximately linear up to 6 months, after which it plateaus. Source: PMID 17490954, permanent link to the source in the list below.
How it works
A mixture of positional and geometric isomers of linoleic acid. The trans-10,cis-12 isomer reduces fat accumulation in animal models via PPAR-dependent mechanisms, but in humans the effect is small, and the same isomer is linked to increased liver fat and worsened insulin sensitivity.
Dosage and intake
Usually 3–4 g per day of the isomer mixture. In a meta-analysis at a median dose of 3.2 g/day, fat loss relative to placebo was 0.09 ± 0.08 kg per week, that is about 0.4 kg per month and about 1 kg over 12 weeks. The effect is approximately linear up to 6 months, after which it plateaus.
The time of intake does not matter; more often it is divided into 2–3 doses with food for tolerability.
Forms
Mixtures of the c9,t11 and t10,c12 isomers, as well as triglyceride forms. The ratio of isomers in supplements is not standardized, and the result depends on it.
What is confirmed
- Meta-analysis of 18 RCTs: at 3.2 g/day, on average 0.09 kg of fat mass per week — about 1 kg over 12 weeks
- The effect is statistically significant, but comparable to the measurement error of body composition and not visible to the eye
- A shift in mass toward muscle has not been shown: lean mass does not increase
Adverse effects and limitations
- The trans-10,cis-12 isomer increased liver fat and worsened insulin sensitivity in some studies
- GI upset, diarrhea and changes in the lipid profile are possible
- The effect plateaus after 6 months, so long-term intake makes no sense
Interactions
- Caution in type 2 diabetes and metabolic syndrome because of a possible effect on insulin sensitivity
- The combination with other fat-burning agents has not been studied
Who must not use it
- Under 18 years: Not recommended: there are no safety or benefit data.
- Pregnancy and lactation: Contraindicated in pregnancy and lactation: the effect on lipid metabolism and development has not been studied.
- type 2 diabetes mellitus
- nonalcoholic fatty liver disease
- hyperlipidemia
- use of lipid-lowering drugs
Sources
- Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans · Whigham LD, Watras AC, Schoeller DA · The American journal of clinical nutrition, 2007 · PMID 17490954
- Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review · Watanabe M, Risi R, Masi D · Nutrients, 2020 · PMID 32962190
See also
Open in the app
This page holds reference data with links to studies. In the app you can calculate calories and macros for your goal, build a personal supplement stack and review weekly training volume.